NLRP3 and type 1 diabetes mellitus: Additionally, over-expression of BMP7 could inhibit NLRP3 inflammasome activation and pyroptosis of NPCs to ameliorate IDD in T1DM (Fig. 8), which emphasizes the potential value of BMP7 in diabetic IDD therapy.